SM

Sarang Matsendranath Degloorkar

Director Director DIN 06813488
DIN 06813488 First appointment Feb 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Sarang Matsendranath Degloorkar

Data last updated:

Sarang Matsendranath Degloorkar was a Director at Gale Pharma (India) Private Limited (2014–2019). The company operates in Pharma.

DIN 06813488
Primary Designation Director
Industry Pharma
First Appointment 12 Feb 2014

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gale Pharma (India) Private Limited U51909TG2013PTC087583
Director12 Feb 20142013₹27.9 Lakh (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gale Pharma (India) Private Limited
Premium access

Shareholding and investment profile for Sarang Matsendranath Degloorkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarang Matsendranath Degloorkar

Sarang Matsendranath Degloorkar was first appointed on 12 Feb 2014 as Director at Gale Pharma (India) Private Limited.

Sarang Matsendranath Degloorkar held 1 earlier board appointment: Gale Pharma (India) Private Limited (Director, 12 Feb 2014 to 01 Jun 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available